Cargando…

17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells

Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Vydra, Natalia, Janus, Patryk, Toma-Jonik, Agnieszka, Stokowy, Tomasz, Mrowiec, Katarzyna, Korfanty, Joanna, Długajczyk, Anna, Wojtaś, Bartosz, Gielniewski, Bartłomiej, Widłak, Wiesława
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826487/
https://www.ncbi.nlm.nih.gov/pubmed/31614463
http://dx.doi.org/10.3390/cancers11101533
_version_ 1783465099459035136
author Vydra, Natalia
Janus, Patryk
Toma-Jonik, Agnieszka
Stokowy, Tomasz
Mrowiec, Katarzyna
Korfanty, Joanna
Długajczyk, Anna
Wojtaś, Bartosz
Gielniewski, Bartłomiej
Widłak, Wiesława
author_facet Vydra, Natalia
Janus, Patryk
Toma-Jonik, Agnieszka
Stokowy, Tomasz
Mrowiec, Katarzyna
Korfanty, Joanna
Długajczyk, Anna
Wojtaś, Bartosz
Gielniewski, Bartłomiej
Widłak, Wiesława
author_sort Vydra, Natalia
collection PubMed
description Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17β-estradiol (E2), as well as xenoestrogen bisphenol A and ERα agonist propyl pyrazole triol, led to HSF1 phosphorylation on S326 in ERα positive but not in ERα-negative mammary breast cancer cells. Furthermore, we showed that MAPK signaling (via MEK1/2) but not mTOR signaling was involved in E2/ERα-dependent activation of HSF1. E2­activated HSF1 was transcriptionally potent and several genes essential for breast cancer cells growth and/or ERα action, including HSPB8, LHX4, PRKCE, WWC1, and GREB1, were activated by E2 in a HSF1-dependent manner. Our findings suggest a hypothetical positive feedback loop between E2/ERα and HSF1 signaling, which may support the growth of estrogen-dependent tumors.
format Online
Article
Text
id pubmed-6826487
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68264872019-11-18 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells Vydra, Natalia Janus, Patryk Toma-Jonik, Agnieszka Stokowy, Tomasz Mrowiec, Katarzyna Korfanty, Joanna Długajczyk, Anna Wojtaś, Bartosz Gielniewski, Bartłomiej Widłak, Wiesława Cancers (Basel) Article Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17β-estradiol (E2), as well as xenoestrogen bisphenol A and ERα agonist propyl pyrazole triol, led to HSF1 phosphorylation on S326 in ERα positive but not in ERα-negative mammary breast cancer cells. Furthermore, we showed that MAPK signaling (via MEK1/2) but not mTOR signaling was involved in E2/ERα-dependent activation of HSF1. E2­activated HSF1 was transcriptionally potent and several genes essential for breast cancer cells growth and/or ERα action, including HSPB8, LHX4, PRKCE, WWC1, and GREB1, were activated by E2 in a HSF1-dependent manner. Our findings suggest a hypothetical positive feedback loop between E2/ERα and HSF1 signaling, which may support the growth of estrogen-dependent tumors. MDPI 2019-10-11 /pmc/articles/PMC6826487/ /pubmed/31614463 http://dx.doi.org/10.3390/cancers11101533 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vydra, Natalia
Janus, Patryk
Toma-Jonik, Agnieszka
Stokowy, Tomasz
Mrowiec, Katarzyna
Korfanty, Joanna
Długajczyk, Anna
Wojtaś, Bartosz
Gielniewski, Bartłomiej
Widłak, Wiesława
17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title_full 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title_fullStr 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title_full_unstemmed 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title_short 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
title_sort 17β-estradiol activates hsf1 via mapk signaling in erα-positive breast cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826487/
https://www.ncbi.nlm.nih.gov/pubmed/31614463
http://dx.doi.org/10.3390/cancers11101533
work_keys_str_mv AT vydranatalia 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT januspatryk 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT tomajonikagnieszka 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT stokowytomasz 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT mrowieckatarzyna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT korfantyjoanna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT długajczykanna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT wojtasbartosz 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT gielniewskibartłomiej 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells
AT widłakwiesława 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells